Adimab LLC Researchers Describe Advances in Immunoglobulins (Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows)

MLA

“Adimab LLC Researchers Describe Advances in Immunoglobulins (Assessment and Incorporation of in Vitro Correlates to Pharmacokinetic Outcomes in Antibody Developability Workflows).” Biotech Business Week, 9 Dec. 2024, p. 81. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.819267873&authtype=sso&custid=ns315887.

APA

Adimab LLC Researchers Describe Advances in Immunoglobulins (Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows). (2024, December 9). Biotech Business Week, 81.

Chicago

Biotech Business Week. 2024. “Adimab LLC Researchers Describe Advances in Immunoglobulins (Assessment and Incorporation of in Vitro Correlates to Pharmacokinetic Outcomes in Antibody Developability Workflows),” December 9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.819267873&authtype=sso&custid=ns315887.